glp-1 agonists diabetes Trends in the Development of Receptor Upcoming wave of hormone-based therapies

Loss of ICC is the most common enteric abnormality in DGp and idiopathic gastroparesis

doi: 10.1111/DOM.14997 31 MaXLiuZIlyasILittlePJKamatoDSahebkaAet al

People who take phentermine and experience progress with weight loss may also need adjustments in the dosages of insulin or other diabetic medications to prevent low blood sugar

Bailey CJ

520 This finding emphasizes the importance of considering metabolic status in cancer treatment and the necessity for further research in this area

In alzheimers disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: Randomized, placebo-controlled, double-blind clinical trial